KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

International Paper (IP) Cash & Equivalents (2016 - 2025)

International Paper (IP) has 17 years of Cash & Equivalents data on record, last reported at $995.0 million in Q3 2025.

  • For Q3 2025, Cash & Equivalents fell 14.15% year-over-year to $995.0 million; the TTM value through Sep 2025 reached $995.0 million, down 14.15%, while the annual FY2024 figure was $1.1 billion, 4.58% down from the prior year.
  • Cash & Equivalents reached $995.0 million in Q3 2025 per IP's latest filing, down from $1.1 billion in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $2.1 billion in Q3 2021 and bottomed at $511.0 million in Q3 2022.
  • Average Cash & Equivalents over 5 years is $1.0 billion, with a median of $1.0 billion recorded in 2024.
  • Peak YoY movement for Cash & Equivalents: surged 212.98% in 2021, then tumbled 75.92% in 2022.
  • A 5-year view of Cash & Equivalents shows it stood at $1.3 billion in 2021, then plummeted by 37.92% to $804.0 million in 2022, then surged by 38.43% to $1.1 billion in 2023, then dropped by 4.58% to $1.1 billion in 2024, then decreased by 6.31% to $995.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $995.0 million in Q3 2025, $1.1 billion in Q2 2025, and $1.2 billion in Q1 2025.